Excelsior Medical Co., Ltd. · TWSE:4104
Excelsior Medical — H1 2021 Earnings Presentation
33 slides from Excelsior Medical's earnings presentation, 2021
Slide 1: Excelsior Medical Co., Ltd. 2021 H1 Investor Conference
Excelsior Medical Co., Ltd. 2021 H1 Investor Conference
Slide 2: Disclaimer
Disclaimer This presentation is prepared according to the reviewed financial statements by CPA and the financial figures hereby are based on IFRS, please refer to the published financial statements for full content. The presentation may contain forward-looking information and may differ materially f
Slide 3: Table of Contents
Table of Contents 1.公司概況(Corporate Overview) P.4 2.市場概況(Market Overview) P.8 3.營運概況(Business Overview) P.11 4.財務概況(Financial Overview) P.14 5.轉投資概況(Investment Overview) P.17 6.2021策略及展望(2021 Strategies and Outlook) P.23 7.補充資料(Appendix) P.26 3
Slide 4: Corporate Overview
Corporate Overview Chairman Group President Tony Fu “Dedication, Discipline, Innovation, Proactive” are the core values of Excelsior. “Human Healthcare” is the basis of medical service industry. Therefore, “Dedication” to our service target is what matters the most. We focus on public healthcare, us
Slide 5: The Most Valuable Total Healthcare Solution Provider among Asia
The Most Valuable Total Healthcare Solution Provider among Asia with Exceptional Investment and Operating Teams！ Excelsior Medical Co., Ltd. was established in 1988, Excelsior started with the distribution of hemodialysis equipments and supplies. Gradually transformed into integrated medical service
Slide 6: Revenue structure
Revenue structure Excelsior yearly consolidated sales is more than NT $ 6.6 billion in 2020, the primary revenue comes from Excelsior (Hemodialysis), Dynamic (Aesthetic Medical), Arich (Pharmaceutical Logistics) and others. According to the company’s function, the business type can be characterized
Slide 7: The Business Types
The Business Types Hemodialysis Aesthetic Medical Trading Business Medical Devices Medical Consumables Home Appliances Product Planning Sales Information Analysis Promotion Hemodialysis channel Medical Information System Market Creative Aesthetic Medical channel Pharmaceutical Distribution Managemen
Slide 8: Market Overview
Market Overview Excelsior(Hemodialysis) Taiwan benefited from the implementation of the national health insurance system in 1995 and the hemodialysis technology and quality gradually mature, the patient's survival rate has gradually increased. According National Health Insurance Administration , as
Slide 9: Dynamic (Aesthetic Medical)
Dynamic(Aesthetic Medical) According to the Asian-Pacific Market Study issued by Medical Insight, Inc. in Mar. 2021, total Asian sales of all aesthetic products and equipment reached US$2.9 billion in 2019 and are expected to increase by 9.6% per year through 2024. Furthermore, medical aesthetic mar
Slide 10: Arich (Pharmaceutical Logistics)
Arich (Pharmaceutical Logistics) Drugs cost approximately 1/4 of National Health Insurance expenditures. In Taiwan, although demand for medication is growing, but the prices approved/reimbursed by NHI are declining. Consequently the multinational pharmaceutical companies keep on outsourcing, for the
Slide 11: Business Overview: Excelsior (Hemodialysis)
Business Overview Excelsior(Hemodialysis) Excelsior’s operating income was NT $ 319,114 Unit: NTD in thousands thousands in 2020 and NT $ 263,303 thousands in 2019; the growth rate was 21.2%. The greater profit in 2021 H1 than which of 2020 H1 is increased because of higher gross margin and control
Slide 12: Dynamic (Aesthetic Medical)
Dynamic(Aesthetic Medical) Operating income was NT $ 140,848 thousands in 2020 and NT $ 157,823 thousands in 2019 due to decline of Unit: NTD in thousands revenues because of the pandemic. However, the company keeps optimizing the portfolio of products that leads to rise of gross margin offsetting t
Slide 13: Arich (Pharmaceutical Logistics)
Arich (Pharmaceutical Logistics) Unit: NTD in thousands ARICH’s operating income was NT$ 48,329 thousands in 2020 and NT$ 65,522 thousands in 2019, mainly due to employee stock subscription fees of cash capital increase in 2020, new storage rents and increased insurance premiums. Affected by COVID-1
Slide 14: Financial Overview
Financial Overview Consolidated gross profit Consolidated revenue Unit: NTD in thousands Unit: NTD in thousands Consolidated Operating Income Unit: NTD in thousands 14
Slide 15: Unit: NTD in thousands Unit: NTD in thousands
Unit: NTD in thousands Unit: NTD in thousands 15
Slide 16: Unit: NTD in thousands Unit : NTD in Dollars
Unit: NTD in thousands Unit : NTD in Dollars 16
Slide 17: Hemodialysis channel – Excelsior Renal Service Co., Limited
Investment Overview Hemodialysis channel – Excelsior Renal Service Co., Limited &Jiate Excelsior Co., Ltd 【 Hemodialysis channel Introduction 】 Excelsior has entered into a joint venture with Fresenius which is the world's largest manufacturer of dialysis products, and has established long-term coop
Slide 18: Hemodialysis channel – Excelsior Renal Service Co., Limited
Hemodialysis channel – Excelsior Renal Service Co., Limited &Jiate Excelsior Co., Ltd Unit : except ERS channels, NTD in thousands 18
Slide 19: Hemodialysis channels
Total % Area ERS channels channels Taipei：21 keelong：3 North 284 34 12.0% Central 200 45 22.5% South 195 21 10.8% other 38 1 2.6% Total 717 101 14.1% Taoyuan：8 Hsinchu：2 Miaoli：2 Taichung：26 Changhua：7 Yilan ：1 Yunlin：2 Nantou：6 Chiayi：2 Tainan：9 pingtung：4 Kaohsiung：8 Hemodialysis channels 19
Slide 20: Long-Term Care Channels– Asia Best Healthcare Co., Ltd.
Long-Term Care Channels– Asia Best Healthcare Co., Ltd. Xi-zhi Nursing Home 內部配置 【 Long-Term Care Channels Introduction 】 Excelsior combines the experiences and advantages in the medical industry, with innovative concepts to build higher service standards of long-term care channels. We provide Long
Slide 21: Long-Term Care Channels– Asia Best Healthcare Co., Ltd.
Long-Term Care Channels– Asia Best Healthcare Co., Ltd. Unit: except ABH Beds, NTD in thousands 招大廳 21
Slide 22: Long-term care channels
Hospital/long-term care Hospital Beds 532 Long-term care channels Long-term care 2,732 Total 3,264 Xizhi keelong：114 beds Taoyuan : 204 beds Taipei：165 beds Ping- zhen New Taipei City： 1,292 beds Taichung：581 beds Tai -chung Changhua: 200 beds Yunlin ：131 beds Kaoh -siung Nantou ：294 beds Tainan ：99
Slide 23: 2021 Strategies and Outlook
2021 Strategies and Outlook Excelsior(Hemodialysis) Long-Term Planning Excelsior develops from Mid-Term Planning Taiwan to Asia, and follows the government’s direction “The Externally, the Company will New Southbound Policy ”, we integrate medical resources, will proceed to focus on introduce compe
Slide 24: Dynamic (Aesthetic Medical)
Dynamic(Aesthetic Medical) Long-Term Planning Southeast Asia Market Mid-Term Planning Strategic Alliance New Product Development Preventive Medicine Home-Use Beauty Device Aesthetic Consumables Body Contouring Market Short-Term Plan Development Launching Cosmetic Brand/Channel Expa
Slide 25: Arich (Pharmaceutical Logistics)
Arich (Pharmaceutical Logistics) Long-Term Planning 1.Sales Promotion A.To seek strategic partners and to expand the variety of Mid-Term Planning our products. B.To integrate Excelsior group’s 1.Sales Promotion dialysis and long term care Actively looking for the centers and to enter into opportunit
Slide 26: Appendix: Balance Sheet
wes Appendix Balance Sheet | Unit:In thousands ND ———CSC~sdYCS209.12.31 | 2020.12.31 | _— 2021.06.30 __ | Assets” C(“‘“‘CS™COC*;*C*C‘*C 2,828,776 2,618,464 2,787,869 4,561,835 1,445,276 1,484,087 2,687,002 2,494,273 2,670,099 |_inventories C‘“‘“‘CS™SC*;*C*S 853,185 851,236 873,528 683,887 1,002,551
Slide 27: Balance Sheet
Balance Sheet Unit: In_ thousands NTD P| 2019.12.31 | 2020.12.31 | 2021.06.30 | 1,212,967 404,498 360,926 4,059,278 882,266 920,283 1,809,771 2,001,349 2,900,624 747,086 731,819 731,562 4,829,102 4,019,932 4,913,395 644 - - 303,326 404,996 364,589 303,970 404,996 364,589 5,133,072 4,424,928 5,277,98
Slide 28: Statement of Comprehensive Income
Statement of Comprehensive Income 28
Slide 29: Statements of Cash Flows
i | i oe] Bee f Cash Flows |Unit:In thousands NTD 209 | 2020S T2021 746,825 829,383 382,845 (108,145) (98,489) 31,251 80,067 112,387 (37,404) 1,085,152 196,476 (71,057) 149,014 (36,471) (43,439) 20,502 (177,012) 38,017 (712,503) 191,162 314,814 (102,255) (97,485) (65,849) | Others CCCs 36,839 (60,51
Slide 30: Statements of Cash Flows
Exceinor Mealtncare Crowe Statements of Cash Flows thousands NTD EE f financial assets at amortized cost (406,787) (620,951) (370,987) = from disposal of financial assets at 113,666 365,699 213,601 amortized cost (359,957) - - 1,859 ; ; Acquisition of property, plant and equipment (51,275) (30,716)
Slide 31: Statements of Cash Flows
eee Statements of Cash Flows lUnit:In thousands NTO | tt 202002 74,867 (808,469) (43,572) (398,607) (4,448) (4,119) Cash dividends paid (384,447) (465,792) - Cc eased by cash - 585,000 - | Others si‘CSCidzC (176,747) 90,425 (40,731) Net Cash Flows used in Financing Activities (884,934) (603,284) (88
Slide 32: Growing up with Long-term partners
Growing up with Long-term partners Excelsior has been operating for 30 years, accumulated core competitiveness with new ideas created, new models to integrate various professional medical fields. Excelsior will keep taking root in the Asia market, the business scope includes Taiwan, Hong Kong, China
Slide 33: Growing up with Long-term partners
Growing up with Long-term partners Excelsior has been operating for 30 years, accumulated core competitiveness with new ideas created, new models to integrate variously professional medical fields. Excelsior will keep take root in the Asia market, the business scope includes Taiwan, Hong Kong, China